As aforementioned, thymol possesses anti-inflammatory in ulcerative colitis acting directly by inhibition of LPS-induced secretion of NO, TNF-α, IL-1β, and IL-6 in macrophages, and suppression of the activation of NF-κB pathway. Here, NFKB1 is linked to ulcerative colitis.